论文信息 - Targeting of cells expressing wild‐type EGFR and type‐III mutant EGFR (EGFRvIII) by anti‐EGFR MAb ICR62: A two‐pronged attack for tumour therapy - 字舞流文

Targeting of cells expressing wild‐type EGFR and type‐III mutant EGFR (EGFRvIII) by anti‐EGFR MAb ICR62: A two‐pronged attack for tumour therapy

H. Modjtahedi | S. Eccles | C. Dean | D. Lamb | H. Thomas | A. Wong | C. Shotton | D. Moscatello | Margaret Green | G. Box | Lesley J. Reynolds